/Companies

Cereius

Durham, US · Founded 2017 · Delaware corporation · 2 known investors

Find your way into Cereius

Sign up to find every way you can get introduced to Cereius

  • Your email: who you already know at Cereius, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cereius team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Next-generation targeted radiotherapeutics for cancer patients.

Founders & leadership

EF
Edward FieldNamed on SEC filing
SH
Susie HarborthNamed on SEC filing
KB
Kimberly BlackwellNamed on SEC filing
MZ
Michael ZalutskyNamed on SEC filing
BH
Bill HawkinsNamed on SEC filing

Board

ELEric Linsley
Eric LinsleyBoard directorManaging Partner at BioInnovation Capital

Investors · 2

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2018

▶$1MraisedAug 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric LinsleyDirector
  • Edward FieldExecutive Officer, Director
  • Susie HarborthDirector
  • Kimberly BlackwellExecutive Officer
  • Michael ZalutskyExecutive Officer, Director
  • Bill HawkinsDirector
Offering amount
$6M
Amount sold
$1M
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Cereius do?
Next-generation targeted radiotherapeutics for cancer patients.
Who are Cereius's investors?
Cereius's investors include Mission Biocapital, BioInnovation Capital.
How much funding has Cereius raised?
Cereius has disclosed $1M raised across 1 round.
Where is Cereius headquartered?
Cereius is headquartered in Durham, US.